Lamivudine and Hepatitis B Reactivation
- Chiun Hsu, MD, PhD;
- Ann-Lii Cheng, MD, PhD; and
- Pei-Jer Chen, MD, PhD
- From National Taiwan University Hospital, Taipei, Taiwan.
TO THE EDITOR:
We read with great interest the systematic review by Loomba and colleagues (1) for chemotherapy-induced hepatitis B virus (HBV) reactivation in patients with cancer who tested positive for HBV surface antigen. However, some of the information quoted in the article needs clarification.
In Table 1 of the article, regarding the use of corticosteroids as an important risk factor for chemotherapy-induced HBV reactivation (2), our study (3) and the study by Lau and colleagues …
RSS Feeds









